Inhibiting STAT3 might unleash an effective anti-lymphoma immune response News-Medical.net Moffitt researchers and colleagues have exploited evidence that suggests the manipulation of the patient's own immune system might prove a good therapeutic strategy for patients with therapy-resistant MCL.
Read this article:
Inhibiting STAT3 might unleash an effective anti-lymphoma immune response – News-Medical.net
Click here for more interesting articles
Tags: Immune support